Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Laramide Resources is a uranium-focused company with significant assets in Australia, and its financials are stable. Learn ...

Based on the Company’s current operating plan, Sage anticipates that its existing cash, cash equivalents, and marketable ...

The company is focused on internal investments, shareholder returns, and strategic opportunities, ending the year with nearly $200 million in cash and marketable securities. Overall, ATEN ranks ...

We view Palantir’s financial position as healthy and improving. As of December, Palantir had nearly $2 billion in cash and $3.1 billion in marketable securities (mostly US Treasury securities) and no ...

We recently published a list of Top 11 AI News and Ratings You Should Take a Look At. In this article, we are going to take a ...

Leaving history behind, Argentina has a system in which the most important foreign exchange transactions take place.

Matt Simmes, President and Chief Operating Officer, commented, "During the first quarter of fiscal 2025, we continued to benefit from the ongoing investments we have ... of cash and $53.0 million of ...